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Moderate alcohol consumption is associated with a significant reduction of cardiovascular mortality in humans [13] . Some studies indicate that wine may be more protective than other liquors such as beer or spirits [14, 15] . A meta-analysis of 26 studies on more than 200,000 individuals revealed that when compared with abstainers, cardiovascular risk was reduced by 22% in beer drinkers, and by 32% in wine drinkers [16] . This and other studies suggest that wine may contain non-alcoholic compounds which, in addition to ethanol, that protect against atherosclerotic vascular disease.
Consistent with this idea the relatively high wine intake in France is thought to account for the lower mortality from coronary heart disease (CHD), which is reduced by 50% compared with other European countries and the USA, despite similar intakes of saturated fats [17, 18] . However, the molecular basis of this phenomenon, commonly known as the 'French paradox', remains unknown.
Red wine polyphenols (RWPs) reduced cardiovascular risk factors such as hypertension and endothelial dysfunction. In fact, chronic administration of RWPs reduces blood pressure and improves endothelial function in DOCA-salt rats, a low renin model of hypertension in which ET-1 plays a predominant role [19, 20] . In these hypertensive rats, RWPs prevent vascular oxidative stress and inhibit NADPH oxidase activity [20] . Similarly, in Zucker rats RWPs reduced O 2 .-release via decreased expression of NADPH oxidase membrane sub-unit Nox-1 [21] . However, it is not clear if these protective effects of RWPs are a result of decreased ET-1 synthesis [20] and/or interference with ET-1 signaling pathways to lead oxidative stress in the vascular wall.
Furthermore, the main compounds of RWPs extract responsible for these protective effects are unknown.
Given the key role of ET-1 and oxidative stress in cardiovascular disease, we have investigated the mechanisms involved in the protective effects of a dietary mixture A c c e p t e d M a n u s c r i p t
of RWPs in ET-1-induced vascular oxidative response and endothelial dysfunction in isolated rat aortic segments. We also tested the effects of the tree main monomeric polyphenols (catechin, epicatechin and resveratrol) included in this RWPs extract.
Methods
All of the procedures conform to the Guide for the Care and Use of Laboratory Animals (National Institutes of Health (NIH) publication no. 85-23, revised 1996) and approved by our Institutional Committee for the ethical care of animals.
Isolation and incubation of rat aortic rings
Experiments were conducted in male Wistar rats obtained from Harlan Laboratories containing an antibiotic-antimycotic mixture (penicillin, gentamicin and anfotericin B)
for 4 h in a cell culture incubator in the absence or presence of ET-1 (10 nM) and in the presence of vehicle (dimethylsulfoxide, DMSO 0.1%), RWPs (10 -4 , 10 -3 and 10 -2 g/L), apocynin (10 -4 M), catechin (0.2 μM), epicatechin (10 μM), or resveratrol (0.1 μM). The concentration of RWPs used in the present study has been found to produce the maximal endothelium-dependent relaxation in rat vascular tissues [22] and was comparable to the concentration of polyphenols present in the plasma with a dose of 20 mg/kg of RWPs when used in vivo experiments [21] . Aortae were immediately used for 
Contractile tension recording
Aortic rings, previously incubated as mentioned above, were mounted in organ chambers by means of two L-shaped stainless-steel wires inserted into the lumen and attached to the chamber and to an isometric force-displacement transducer coupled to a signal amplifier (Dynamometer UF1, Cibertec, Madrid) and connected to a computer via an A/D interface. Contractile tension was recorded by a PowerLab 800 (AD Instruments, Cibertec, Madrid), as previously described [23] . The chamber was filled with Krebs solution at 37 ºC and gassed with 95% O 2 and 5% CO 2 . Rings were stretched to 2 g of tension and equilibrated for 90-120 min. During this period, Krebs solution was changed every 30 min and rings were re-stretched as needed to maintain a final tension of 2 g. After equilibration, arteries were stimulated with phenylephrine (1 μM or 0.1 μM, in control or ET-1 treated aortic rings, respectively, to obtain similar level of precontraction) and a concentration-response curve was constructed by cumulative addition of acetylcholine (ACh). In some experiments, endotheliumindependent responses to sodium nitroprusside were also performed in the dark in rings pre-contracted with 1 μM phenylephrine. To evaluate the participation of endothelial NO on endothelial dysfunction induced by ET-1, several aortic rings were incubated with or without eNOS inhibitor L-NAME (100 μM) in organ chambers for 30 min before the addition of phenylephrine (10 -9 M-10 -4 M). A c c e p t e d M a n u s c r i p t
http://rsb.info.nih/ij/). O 2 .-production was estimated from the ratio of ethidium /DAPI fluorescence [24] .
NADPH oxidase activity
The lucigenin-enhanced chemiluminescence assay was used to determine NADPH A c c e p t e d M a n u s c r i p t
annealing at 60°C for p47phox , 55°C for p22phox, 55ºC for caveolin-1, or 63ºC for eNOS, and 1 min for enzymatic primer extension at 72°C. After the final cycle, the temperature was held at 72°C for 10 min to allow reannealing of amplified products.
RT-PCR products were then size-fractionated through a 1.5 % agarose gel, and the bands were visualized with ethidium bromide and quantified by densitometric analysis performed on the scanned images using Scion Image-Release Beta 4.02 software A c c e p t e d M a n u s c r i p t
B1; 21.1 B2; 7.4 B3), 176.3 anthocyanins, 4.7 gallic acid, 15.1 p-coumaric acid and 1.5
resveratrol. All drugs and reagents were from Sigma, except DAPI from Calbiochem.
RWPs, apocynin, catechin, epicatechin and resveratrol were initially dissolved in DMSO and all other drugs in distilled water.
Statistical analysis
Results are expressed as means ± standard error of mean and n reflects the number of animals. Statistically significant differences between groups were calculated by Students´ t test for unpaired observations or for multiple comparisons by an analysis of variance (ANOVA) followed by a Newman Keuls test. P < 0.05 was considered statistically significant. Concentration-response curves were fitted to the logistic
, where E max is the maximal effect, k is a factor which represents the slope of the curve, and pD 2 is the drug concentration exhibiting 50% of the E max expressed as negative log molar.
Results

Effects of RWPs on endothelial dysfunction
Incubation of the aortic rings for 4 h in the absence of ET-1 produced no significant changes in the contractile response to phenylephrine or in the relaxant response to ACh (data not shown). ET-1 led to the development of endothelial dysfunction as indicated by the reduction in the maximal relaxant effect of ACh ( Figure   1A , Table 1 ) and by the increased contractile response to phenylephrine ( Figure 1C ). A c c e p t e d M a n u s c r i p t
Incubation with RWPs for 4 h prevented ET-1-induced endothelial dysfunction in a concentration-dependent manner ( Figure 1A ) and decreased the contractile response to phenylephrine ( Figure 1C ) in ET-1-treated arteries. Similarly, the NADPH oxidase inhibitor apocynin also restored the impaired relaxant response to ACh induced by ET-1 (Figure1B). The relaxant response to ACh was suppressed by NO synthase inhibition with L-NAME, in both control and ET-1 treated aortic rings (data not shown). The concentration-contractile response induced by phenylephrine in intact aortic rings was significantly reduced in aortae incubated with ET-1 as compared with control group when the rings were incubated previously with L-NAME, indicating a reduced basal NO formation in ET-1-treated rings. RWPs (10 -3 g/L) increased this contractile response, suggesting a higher eNOS activity in these vessels ( Figure 1D ).
In order to determine if stretch could modify the effects of ET-1 on endothelial dysfunction, in another set of experiments, rings were first mounted in the organ chambers and then incubated with or without ET-1 for 4 h. Afterwards, after removing ET-1, the relaxant response to ACh was analyzed in phenylephrine pre-contracted rings.
Under these more physiological experimental conditions, ET-1 incubation also impaired the vasodilatation induced by ACh as compared with control rings (Maximal effects (%):
35.2 ± 4.6, n = 6; 69.2 ± 5.1, n = 6, respectively, P< 0.01).
No differences were observed in the endothelium-independent relaxant responses to the endothelium-independent vasodilator sodium nitroprusside in arteries A c c e p t e d M a n u s c r i p t
In order to characterize O 2 .-production and localize it within the vascular wall, ethidium A c c e p t e d M a n u s c r i p t NAME (100 μM), endothelial denudation (not shown) and by co-incubation with RWPs (10 -3 g/L) ( Figure 4B ). A c c e p t e d M a n u s c r i p t
Effects of RWPs on ET
and RWPs (10 -2 g/L). RWPs improvement of ET-1-induced impaired ACh relaxation was unaffected by GW9662 ( Figure 7B ).
ERK1/2 has been recently involved in ET-1 signalling pathway to increase NADPH oxidase-driven O 2 .-production in vascular wall [12] . In our experiments, aortic incubation with ET-1 for 1 h induced ERK1/2 phosphorylation, which was prevented by coincubation with RWPs (10 -3 g/L) ( Figure 7C ).
Effects of isolated polyphenols in functional and biochemical changes induced by
ET-1
When we tested the effects of catechin, epicatechin and resveratrol in the endothelial A c c e p t e d M a n u s c r i p t
endothelial dysfunction can be prevented by RWPs, independently of their possible interference with ET-1 production. Moreover, these RWPs also prevented the ET-1-induced increase in vascular O 2 .-production from both NADPH oxidase through downregulation of p47 phox expression and from uncoupled eNOS. These protective effects seemed to be independent of both ERα and PPARγ activation but related to ERK1/2 inhibition.
Endothelial dysfunction is present in several experimental models in which ET-1 plays a predominant pathophysiological role such as 1) the DOCA-salt hypertensive rats, a low renin-angiotensin model of hypertension [7] , 2) streptozotocin-induced diabetic A c c e p t e d M a n u s c r i p t
regulator caveolin-1 in aorta was not altered by ET-1 or co-incubation with RWPs.
Moreover, RWPs did not increase eNOS phosphorylation. However, eNOS activity, indirectly measured by phenylephrine contraction in presence of L-NAME, was reduced by ET-1 and restored by RWPs. These data are consistent to the improvement of eNOS uncoupling induced by RWPs. and polyethylene-glycol SOD, a cell-permeant O 2 .-scavenger, completely prevented the impairment in endothelium dependent relaxation to ACh induced by ET-1. In our study, apocynin, which selectively inhibits NADPH oxidase activity, reversed the impaired relaxant response to ACh in ET-1 treated rings. These results showed the critical role of NADPH oxidase activity modulating vascular tone. However, caution might be taken with this result, since apocynin in vitro is not a specific inhibitor of NADPH oxidase [37] .
We found that ET-1-induced an increase in DHE staining in medial and adventitial layers of the vessel and an increase in NADPH oxidase activity in aortic rings, an effect which was prevented by coincubation with apocynin. Coincubation of RWPs with ET-1 also prevented both the increased vascular O 2 .-production and the increased NADPH oxidase activity. These experiments were carried in rings that had been treated previously with ET-1 and RWPs for 4 h but the actual measurements were done in the absence of ET-1 and RWPs, which suggested a possible interference with the expression rather than the activity of NADPH oxidase subunits. In fact, aortic rings A c c e p t e d M a n u s c r i p t
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Results are means ± SEM, n = 5-7, * and ** indicate P < 0.05 and P < 0.01, respectively, vs control rings, # and ## indicate P < 0.05 and P < 0.01, respectively, vs ET-1-treated rings. A c c e p t e d M a n u s c r i p t
Licenced copy. Copying is not permitted, except with prior permission and as allowed by law. ET-1+ apocynin 6 2.14 ± 0.28 7.08 ± 0.13 57.2 ± 11.8#
Values are means ± SEM. ** indicate P < 0.01, vs control rings; # and ## indicate P < 0.05 and P < 0.01, respectively, vs ET-1-treated rings. A c c e p t e d M a n u s c r i p t
